Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Crossref DOI link: https://doi.org/10.1186/s12879-016-1487-1
Published Online: 2016-04-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kasule, George W.
Kateete, David P.
Joloba, Moses L.